|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.425 USD | -1.90% |
|
-8.52% | -40.52% |
| 29/05 | Sector Update: Health Care Stocks Lean Lower Premarket Wednesday | MT |
| 29/05 | Cytek Biosciences Gets Approval for Clinical Use of TBNK Reagents in China | MT |
On June 1, 2022, Cytek Biosciences, Inc. held its 2022 annual meeting of stockholders, elected Deborah Neff, Don Hardison as Class I director.
| 1st Jan change | Capi. | |
|---|---|---|
| -40.52% | 73Cr | |
| +7.32% | 22TCr | |
| +13.83% | 19TCr | |
| +20.48% | 14TCr | |
| +31.33% | 11TCr | |
| +3.08% | 6.43TCr | |
| +14.64% | 5.29TCr | |
| +2.72% | 4.95TCr | |
| -5.88% | 3.83TCr | |
| +0.25% | 3.52TCr |
CYTEK BIOSCIENCES, INC. 
